Let's talk about Zscaler, because the story here doesn't make sense unless you zoom all the way out — and even then, it still kinda hurts.

On May 27, Zscaler dropped its Q3 FY2026 earnings. By every near-term measure, it was a beat. Revenue of $850.5M, clearing the $835M estimate. Non-GAAP EPS of $1.08, above the $1.01 consensus. The machine is running. And the market responded by torching 31% of the company's value in a single session — the worst single-day collapse in Zscaler's history as a public company.

That's the kind of move that makes you check whether the CEO resigned mid-call or the SEC showed up at headquarters. Neither happened. What happened was guidance: Zscaler told the street it expects FY2027 ARR growth of 16-17%. For a stock still priced for 25%-plus expansion, that number landed like a grenade in the boardroom.

So the question everybody's asking: is this a temporary reset — or the new baseline?

Let's start with the good stuff, because there is plenty of it. Zscaler's Zero Trust Exchange is still one of the most formidable products in enterprise cybersecurity. 45% of the Fortune 500 are customers. That's a near-monopoly on the top end of the market. Data Security, one of Zscaler's newer growth engines, crossed $500M in annual recurring revenue and is growing north of 30% year-over-year. On June 25, the company announced a global cybersecurity partnership with the Aston Martin Aramco Formula One team — the kind of brand-anchor deal that signals enterprise trust at the highest level. And Project Glasswing, Zscaler's collaboration with Anthropic on AI security, positions the company exactly where the puck is going.

Now the uncomfortable part. Zscaler is guiding for 16-17% ARR growth in FY2027, down from the 25%+ clip it was running. Sales leadership departures were disclosed alongside the earnings report, which never helps the narrative. The stock is down 53.2% over the past twelve months, currently trading at $147.33 — less than half the 52-week high of $336.99. At the low of $114.63, it was genuinely getting crushed. The forward P/E sits at 32x. That's not expensive for a high-quality software business, but it's not cheap either — especially when growth is decelerating into the mid-teens.

Here's where the math gets interesting, and where the bullish case starts to build. Zscaler generated $890.3 million in free cash flow over the trailing twelve months. That's a free cash flow margin of roughly 28% — elite by any standard. The company has $3.54 billion in cash on the balance sheet. The GAAP net income loss of $77.4M is almost entirely explained by $661M in annual stock-based compensation. Strip that out, and the underlying cash generation is monstrous. At a market cap of $23.82B, Zscaler trades at roughly 7.5x trailing sales and an FCF yield approaching 3.7%. For a company still growing revenue at 25.4% year-over-year on a TTM basis, those multiples start to look attractive.

Wall Street is not unified on this name, but the consensus leans bullish. 44 analysts cover the stock with a consensus Buy rating and a mean price target of $192.58, implying about 30.7% upside from current levels. The high target sits at $250; the low is $145, meaning even the most bearish analyst is only about 1.5% below today's price.

The bear case is straightforward: if 16-17% growth is the new normal, this is a mid-teens grower trading at 32x forward earnings — not a steal, especially if macro headwinds push growth lower. The $661M in stock comp is a real dilutive cost. And sales leadership turnover at a moment of deceleration raises execution risk that's hard to model.

The bull case is equally simple: a zero-trust platform with 45% of the Fortune 500 locked in, $500M in data security ARR growing 30%+, $890M in FCF, and a balance sheet with more cash than debt. The growth reset from 25% to 16% might be a one-time guide-down, not a permanent re-rating. If FY2028 ARR re-accelerates — and the AI security tailwind from Project Glasswing suggests it could — then buying at $147 will look like the trade of the year.

Zscaler at $147 is a bet on whether the market overreacted to a growth guide-down or correctly priced a mature company. The numbers say there's still a lot of fight left in this dog. Whether that's enough to win back the growth crowd — that's what the next two quarters will decide.

Disclosure: The Signal holds no position in ZS. Positions may change. This is not financial advice.